This vertigo drug triples your fall risk

Vertigo is unsettling, and it’s natural to want quick relief, often in the form of a small pill prescribed to calm dizziness. But new research in JAMA Otolaryngology–Head & Neck Surgery warns that while it may ease symptoms in the moment, it can significantly raise your fall risk.

Meclizine is an antihistamine that suppresses inner ear signals to reduce vertigo and nausea. It’s been used for decades in the U.S., often given in clinics and ERs when patients complain of dizziness.

The problem: vertigo itself already raises fall risk, and meclizine adds side effects—drowsiness, slower reactions, blurred vision—that make matters worse. Despite caution in medical guidelines, it’s still widely prescribed.

Researchers analyzed U.S. insurance claims from 2006 to 2015, covering 805,454 adults newly diagnosed with dizziness (average age 52; 62% women). They checked if patients filled a meclizine prescription within 30 days and tracked falls serious enough for medical care within 60 days.

Findings:

● 8% of patients received meclizine

● Among them, 9% had a fall within 60 days

● Younger adults (18–64): 3x higher fall risk

● Older adults (65+): 2.5x higher fall risk

Before automatically reaching for medication, remember that most vertigo cases can be managed with natural, proven methods.

In fact, our vertigo exercises work for all types of vertigo. Thousands of readers swear by their effectiveness. And you can learn them in minutes and feel the difference today. Check them out here…